Replimune Group Inc
REPL
$10.86-7.57%
End of day · as of Oct 17, 2026, 2:00 AM ET
Mkt cap
$825.73M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2026)
N/A
EPS (9mo ended 2025-12-31)
$-2.62
Gross Margin (FY2026)
N/A
Profit Margin (FY2026)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Use this REPL research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full REPL income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Replimune Group Inc (REPL) is a biotechnology company in the Healthcare sector.
Latest cached Replimune Group Inc (REPL) net income for FY2026 was -$313.9M. Statements: https://lician.com/financials/repl
Replimune Group Inc (REPL) market capitalization is $825.7M on the latest cached snapshot.
Replimune Group Inc (REPL) cached previous close $11.75; day range $10.86 – $11.73; volume 1,710,451. Session quote: https://lician.com/quote/repl